1Taylor, D, Paton, C, Kerwin, R. The South London and Maudsley NHS Foundation Trust and Oxleas Foundation Trust Prescribing Guidelines (12th edn). Informa Healthcare, 2015.
2Rajkumar, AP, Poonkuzhali, B, Kuruvilla, A, Jacob, M, Jacob, KS. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia. Int Clin Psychopharmacol 2013; 28: 50–6.
3Pirmohamed, M, Williams, D, Madden, S, Templeton, E, Park, BK. Metabolism and bioactivation of clozapine by human liver in vitro. J Pharmacol Exp Ther 1995; 272: 984–90.
4Chetty, M, Murray, M. CYP-mediated clozapine interactions: how predictable are they? Curr Drug Metab 2007; 8: 307–13.
5Bowskill, S, Couchman, L, MacCabe, JH, Flanagan, RJ. Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged 65 years and over: data from a therapeutic drug monitoring service, 1996–2010. Hum Psychopharmacol 2012; 27: 277–83.
6Bersani, FS, Capra, E, Minichino, A, Pannese, R, Girardi, N, Marini, I, et al. Factors affecting inter individual differences in clozapine response: a review and case report. Hum Psychopharmacol 2011; 26: 177–87.
7Olsson, E, Edman, G, Bertilsson, L, Hukic, DS, Lavebratt, C, Eriksson, SV, et al. Genetic and clinical factors affecting plasma clozapine concentration. Prim Care Companion CNS Disord 2015; 17. doi:10.4088/PCC.14m01704.
8Lowe, EJ, Ackman, ML. Impact of tobacco smoking cessation on stable clozapine or olanzapine treatment. Ann Pharmacother 2010; 44: 727–32.
9Lohr, JB, Flynn, K. Smoking and schizophrenia. Schizophr Res 1992; 8: 93–102.
10Meiklejohn, C, Sanders, K, Butler, S. Physical health in medium secure services. Nurs Stand 2003; 17: 33–7.
11Wu, BJ, Lan, TH. Predictors of smoking reduction outcomes in a sample of 287 patients with schizophrenia spectrum disorders. Eur Arch Psychiatry Clin Neurosci 2017; 267: 63–72.
12World Health Organisation. Classifications of Mental and Behavioural Disorder: Clinical Descriptions and Diagnostic Guidelines , 1992.
13Clarke, JG, Stein, LA, Martin, RA, Martin, SA, Parker, D, Lopes, CE, et al. Forced smoking abstinence: not enough for smoking cessation. JAMA Intern Med 2013; 173: 789–94.
14Lincoln, T, Tuthill, RW, Roberts, CA, Kennedy, S, Hammett, TM, Langmore-Avila, E, et al. Resumption of smoking after release from a tobacco-free correctional facility. J Correct Health Care 2009; 15: 190–6.
15Murayama-Sung, L, Ahmed, I, Goebert, D, Alaimalo, E, Sung, H. The impact of hospital smoking ban on clozapine and norclozapine levels. J Clin Psychopharmacol 2011; 31: 124–6.
16Rostami-Hodjegan, A, Amin, AM, Spencer, EP, Lennard, MS, Tucker, GT, Flanagan, RJ. Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients. J Clin Psychopharmacol 2004; 24: 70–8.
17de Leon, J. Atypical antipsychotic dosing: the effect of smoking and caffeine. Psychiatr Serv 2004; 55: 491–3.
18Taylor, G, McNeill, A, Girling, A, Farley, A, Lindson-Hawley, N, Aveyard, P. Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ 2014; 348: g1151.